<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activity of <z:chebi fb="3" ids="16335">adenosine</z:chebi> deaminase (EC 3.5.4.4) was studied in thrombocytes of donors and patients with various <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The enzymatic activity was decreased in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloleukemia, <z:hpo ids='HP_0005558'>chronic leukemia</z:hpo> and blast transformation <z:mp ids='MP_0009440'>myeloma</z:mp>, microspherocytic and <z:hpo ids='HP_0001908'>hypoplastic anemias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Variable level of the activity was observed in <z:hpo ids='HP_0011010'>chronic</z:hpo> lympholeukemia and non-<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> the diseases studied functions of thrombocytes were altered after treatment with various aggregating agents (<z:chebi fb="13" ids="16761">ADP</z:chebi>, thrombin, collagen, <z:chebi fb="47" ids="28918,33568">adrenaline</z:chebi>, ristomycin) </plain></SENT>
</text></document>